Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Franco Merlo

Showing results (51-60 of 82) with videos related to

Pageof 9
Sort By:
Translational Research : the Journal of Laboratory and Clinical Medicine|June 28, 2012
HOXA7, 9, and 10 are methylation targets associated with aggressive behavior in meningiomasAngela Di Vinci, Claudio Brigati, Ida Casciano, et al.
Mutation Research|July 11, 2006
Cytogenetic effects in children and mothers exposed to air pollution assessed by the frequency of micronuclei and fluorescence in situ hybridization (FISH): a family pilot study in the Czech RepublicMarie Pedersen, Peter Vinzents, Joergen Holm Petersen, et al.
Anesthesia and Analgesia|November 13, 2012
The postoperative analgesic efficacy of preperitoneal continuous wound infusion compared to epidural continuous infusion with local anesthetics after colorectal cancer surgery: a randomized controlled multicenter studySergio Bertoglio, Fabio Fabiani, Pasquale De Negri, et al.
Oncotarget|March 20, 2018
Combined vemurafenib and fotemustine in patients with BRAF V600 melanoma progressing on vemurafenibPaola Queirolo, Francesco Spagnolo, Virginia Picasso, et al.
Acta Bio-Medica : Atenei Parmensis|January 19, 2019
Bioethics in Italian Medical and Healthcare Education. A Pilot StudyMatteo Gulino, Sara Patuzzo, Ilaria Baldelli, et al.
Cancer Immunology, Immunotherapy : CII|February 10, 2012
Evaluation of CTLA-4 expression and relevance as a novel prognostic factor in patients with non-small cell lung cancerSandra Salvi, Vincenzo Fontana, Simona Boccardo, et al.
Disease Markers|December 15, 2015
Expression of Ribonucleotide Reductase Subunit-2 and Thymidylate Synthase Correlates with Poor Prognosis in Patients with Resected Stages I-III Non-Small Cell Lung CancerFrancesco Grossi, Maria Giovanna Dal Bello, Sandra Salvi, et al.
Oncotarget|February 9, 2018
Genome-wide profiling identifies the THYT1 signature as a distinctive feature of widely metastatic Papillary Thyroid CarcinomasGreta Gandolfi, Moira Ragazzi, Dario de Biase, et al.
BMC Cancer|March 30, 2013
Randomised phase 3 open-label trial of first-line treatment with gemcitabine in association with docetaxel or paclitaxel in women with metastatic breast cancer: a comparison of different schedules and treatmentsLucia Del Mastro, Alessandra Fabi, Mauro Mansutti, et al.
BMC Cancer|August 2, 2017
PUREAIR protocol: randomized controlled trial of intensive pulmonary rehabilitation versus standard care in patients undergoing surgical resection for lung cancerStefania Fugazzaro, Stefania Costi, Carlotta Mainini, et al.
Pageof 9

Showing results (51-60 of 82) with videos related to

Sort By:
Pageof 9
Translational Research : the Journal of Laboratory and Clinical Medicine|June 28, 2012
HOXA7, 9, and 10 are methylation targets associated with aggressive behavior in meningiomasAngela Di Vinci, Claudio Brigati, Ida Casciano, et al.
Mutation Research|July 11, 2006
Cytogenetic effects in children and mothers exposed to air pollution assessed by the frequency of micronuclei and fluorescence in situ hybridization (FISH): a family pilot study in the Czech RepublicMarie Pedersen, Peter Vinzents, Joergen Holm Petersen, et al.
Anesthesia and Analgesia|November 13, 2012
The postoperative analgesic efficacy of preperitoneal continuous wound infusion compared to epidural continuous infusion with local anesthetics after colorectal cancer surgery: a randomized controlled multicenter studySergio Bertoglio, Fabio Fabiani, Pasquale De Negri, et al.
Oncotarget|March 20, 2018
Combined vemurafenib and fotemustine in patients with BRAF V600 melanoma progressing on vemurafenibPaola Queirolo, Francesco Spagnolo, Virginia Picasso, et al.
Acta Bio-Medica : Atenei Parmensis|January 19, 2019
Bioethics in Italian Medical and Healthcare Education. A Pilot StudyMatteo Gulino, Sara Patuzzo, Ilaria Baldelli, et al.
Cancer Immunology, Immunotherapy : CII|February 10, 2012
Evaluation of CTLA-4 expression and relevance as a novel prognostic factor in patients with non-small cell lung cancerSandra Salvi, Vincenzo Fontana, Simona Boccardo, et al.
Disease Markers|December 15, 2015
Expression of Ribonucleotide Reductase Subunit-2 and Thymidylate Synthase Correlates with Poor Prognosis in Patients with Resected Stages I-III Non-Small Cell Lung CancerFrancesco Grossi, Maria Giovanna Dal Bello, Sandra Salvi, et al.
Oncotarget|February 9, 2018
Genome-wide profiling identifies the THYT1 signature as a distinctive feature of widely metastatic Papillary Thyroid CarcinomasGreta Gandolfi, Moira Ragazzi, Dario de Biase, et al.
BMC Cancer|March 30, 2013
Randomised phase 3 open-label trial of first-line treatment with gemcitabine in association with docetaxel or paclitaxel in women with metastatic breast cancer: a comparison of different schedules and treatmentsLucia Del Mastro, Alessandra Fabi, Mauro Mansutti, et al.
BMC Cancer|August 2, 2017
PUREAIR protocol: randomized controlled trial of intensive pulmonary rehabilitation versus standard care in patients undergoing surgical resection for lung cancerStefania Fugazzaro, Stefania Costi, Carlotta Mainini, et al.
Pageof 9